nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexfenfluramine—CYP2A6—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.0962	0.0962	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.0843	0.0843	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.076	0.076	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.0666	0.0666	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.0539	0.0539	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.0473	0.0473	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.0457	0.0457	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.0401	0.0401	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0271	0.0271	CbGpPWpGaD
Dexfenfluramine—SLC6A4—NRF2 pathway—ADH7—pharynx cancer	0.0258	0.0258	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.0237	0.0237	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0214	0.0214	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.0188	0.0188	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0165	0.0165	CbGpPWpGaD
Dexfenfluramine—CYP2A6—NRF2 pathway—ADH7—pharynx cancer	0.0164	0.0164	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Biological oxidations—CNDP2—pharynx cancer	0.0159	0.0159	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0152	0.0152	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0151	0.0151	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.0145	0.0145	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Biological oxidations—ADH7—pharynx cancer	0.0144	0.0144	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.0133	0.0133	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.0132	0.0132	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Phase II conjugation—CNDP2—pharynx cancer	0.0129	0.0129	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0129	0.0129	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Biological oxidations—ADH1B—pharynx cancer	0.0126	0.0126	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Biological oxidations—CNDP2—pharynx cancer	0.0126	0.0126	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Biological oxidations—ADH7—pharynx cancer	0.0114	0.0114	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.0113	0.0113	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Biological oxidations—ADH1B—pharynx cancer	0.00997	0.00997	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Biological oxidations—CNDP2—pharynx cancer	0.0097	0.0097	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Biological oxidations—CNDP2—pharynx cancer	0.00892	0.00892	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Biological oxidations—CNDP2—pharynx cancer	0.00884	0.00884	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Biological oxidations—ADH7—pharynx cancer	0.00877	0.00877	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Biological oxidations—ADH7—pharynx cancer	0.00807	0.00807	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Biological oxidations—ADH7—pharynx cancer	0.008	0.008	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Biological oxidations—ADH1B—pharynx cancer	0.00769	0.00769	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Biological oxidations—CNDP2—pharynx cancer	0.00756	0.00756	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Biological oxidations—ADH1B—pharynx cancer	0.00707	0.00707	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Biological oxidations—ADH1B—pharynx cancer	0.00701	0.00701	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Biological oxidations—ADH7—pharynx cancer	0.00683	0.00683	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Fluoropyrimidine Activity—TP53—pharynx cancer	0.00677	0.00677	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Biological oxidations—ADH1B—pharynx cancer	0.00599	0.00599	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—pharynx cancer	0.00294	0.00294	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—pharynx cancer	0.00294	0.00294	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—CNDP2—pharynx cancer	0.00272	0.00272	CbGpPWpGaD
Dexfenfluramine—SLC6A4—Circadian rythm related genes—TP53—pharynx cancer	0.00251	0.00251	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—ADH7—pharynx cancer	0.00246	0.00246	CbGpPWpGaD
Dexfenfluramine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pharynx cancer	0.00243	0.00243	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—ADH1B—pharynx cancer	0.00216	0.00216	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—CNDP2—pharynx cancer	0.00215	0.00215	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—B4GALT5—pharynx cancer	0.00206	0.00206	CbGpPWpGaD
Dexfenfluramine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pharynx cancer	0.00196	0.00196	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—ADH7—pharynx cancer	0.00194	0.00194	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—ADH1B—pharynx cancer	0.0017	0.0017	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—CNDP2—pharynx cancer	0.00166	0.00166	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—B4GALT5—pharynx cancer	0.00163	0.00163	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—CNDP2—pharynx cancer	0.00153	0.00153	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—CNDP2—pharynx cancer	0.00151	0.00151	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—ADH7—pharynx cancer	0.0015	0.0015	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—ADH7—pharynx cancer	0.00138	0.00138	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—ADH7—pharynx cancer	0.00137	0.00137	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—ADH1B—pharynx cancer	0.00131	0.00131	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CNDP2—pharynx cancer	0.00129	0.00129	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—B4GALT5—pharynx cancer	0.00126	0.00126	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—ADH1B—pharynx cancer	0.00121	0.00121	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—ADH1B—pharynx cancer	0.0012	0.0012	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—ADH7—pharynx cancer	0.00117	0.00117	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—B4GALT5—pharynx cancer	0.00116	0.00116	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—B4GALT5—pharynx cancer	0.00115	0.00115	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—ADH1B—pharynx cancer	0.00102	0.00102	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—B4GALT5—pharynx cancer	0.000979	0.000979	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—EGFR—pharynx cancer	0.000703	0.000703	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—EGFR—pharynx cancer	0.000567	0.000567	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CCND1—pharynx cancer	0.000529	0.000529	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CCND1—pharynx cancer	0.000427	0.000427	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—EGFR—pharynx cancer	0.000415	0.000415	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—TP53—pharynx cancer	0.000349	0.000349	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—EGFR—pharynx cancer	0.000335	0.000335	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—TP53—pharynx cancer	0.000281	0.000281	CbGpPWpGaD
